← Leaderboards
Melody Ann Roberts
Liv Labs Inc.
$1,279,586
Attributed
$2,236,995
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $951.5K · FY2021–24$1M$750K$500K$250K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$2,236,995 · 1
By mechanism
R44$2,236,995 · 1
Top collaborators
- Christina Gaupp1 shared
- Lisa Hickman1 shared
- Holly E Richter1 shared
Most similar at Liv Labs Inc.
Same institution · by research overlap
- Christina Gaupp$475,746
- Lisa Hickman$240,832
Others in their field
Other Emerging Leaders on “Diagnosis”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$141,100,782
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
Research focus
DiagnosisEfficacy StudyDevicesCostCreamAdoptionAnatomyDesignComputer SoftwareConsumptionAging In PlaceCareerAmericanCaringChronic DiseaseClient SatisfactionAnteriorClinical CareAtrophicAffectBiomaterial CompatibilityConsumer ProductBladderEngineering
Grant awards (3)
Phase IIB Clinical and Nonclinical Testing of Soft Spring Continence Pessary for Women, in Support of FDA 510(k) Clearance Requirements$563,008
R44 · FY2024 · HD · contact PI
Soft Spring Continence Pessary for Women$722,496
R44 · FY2022 · HD · contact PI
Soft Spring Continence Pessary for Women$951,491
R44 · FY2021 · HD · contact PI